Randomized Phase II Trial of Weekly vs. Every 2 Weeks vs. Every 3 Weeks Nanoparticle Albumin-Bound Paclitaxel With Bevacizumab as First-Line Chemotherapy for Metastatic Breast Cancer
Title:
Randomized Phase II Trial of Weekly vs. Every 2 Weeks vs. Every 3 Weeks Nanoparticle Albumin-Bound Paclitaxel With Bevacizumab as First-Line Chemotherapy for Metastatic Breast Cancer
Author:
Seidman, Andrew D. Conlin, Alison K. Bach, Ariadne Moynahan, Mary Ellen Lake, Diana Forero, Andres Wright, Gail Shaw Hackney, Mary Helen Clawson, Alicia Norton, Larry Hudis, Clifford A.